CASP1 and breast carcinoma: In addition, caspase‐1 mRNA expression was found to be significantly decreased in the breast cancer tissues of patients, and treatment with a caspase-1 inhibitor markedly increased the proliferative and invasive abilities of MDA‐MB‐231 cells34.